{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:53:10Z","timestamp":1778777590575,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s00417-014-2749-5","type":"journal-article","created":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T23:51:43Z","timestamp":1407109903000},"page":"1755-1762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival"],"prefix":"10.1007","volume":"252","author":[{"given":"Parisa","family":"Emami-Naeini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas H.","family":"Dohlman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Omoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yihe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Dana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"key":"2749_CR1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4049\/jimmunol.0903180","volume":"184","author":"T Dietrich","year":"2010","unstructured":"Dietrich T, Bock F, Yuen D et al (2010) Cutting edge: lymphatic vessels, not blood vessels, primarily mediate immune rejections after transplantation. J Immunol 184:535\u2013539. doi: 10.4049\/jimmunol.0903180","journal-title":"J Immunol"},{"key":"2749_CR2","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1167\/iovs.03-1380","volume":"45","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Cao J, Chen L et al (2004) Inhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survival. Invest Ophthalmol Vis Sci 45:2666\u20132673. doi: 10.1167\/iovs.03-1380","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archopht.126.1.71","volume":"126","author":"BO Bachmann","year":"2008","unstructured":"Bachmann BO, Bock F, Wiegand SJ et al (2008) Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation. Arch Ophthalmol 126:71\u201377. doi: 10.1001\/archopht.126.1.71","journal-title":"Arch Ophthalmol"},{"key":"2749_CR4","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1167\/iovs.09-3745","volume":"51","author":"MH Dastjerdi","year":"2010","unstructured":"Dastjerdi MH, Saban DR, Okanobo A et al (2010) Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. Invest Ophthalmol Vis Sci 51:2411\u20132417. doi: 10.1167\/iovs.09-3745","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2353\/ajpath.2007.060896","volume":"171","author":"T Dietrich","year":"2007","unstructured":"Dietrich T, Onderka J, Bock F et al (2007) Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade. Am J Pathol 171:361\u2013372","journal-title":"Am J Pathol"},{"key":"2749_CR6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","volume":"113","author":"C Cursiefen","year":"2004","unstructured":"Cursiefen C, Chen L, Borges LP et al (2004) VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J Clin Invest 113:1040\u20131050. doi: 10.1172\/JCI20465","journal-title":"J Clin Invest"},{"key":"2749_CR7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","volume":"25","author":"CNJ McGhee","year":"2002","unstructured":"McGhee CNJ, Dean S, Danesh-Meyer H (2002) Locally administered ocular corticosteroids: benefits and risks. Drug Saf 25:33\u201355","journal-title":"Drug Saf"},{"key":"2749_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00003226-199807000-00011","volume":"17","author":"MR Dana","year":"1998","unstructured":"Dana MR, Zhu SN, Yamada J (1998) Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17:403\u2013409","journal-title":"Cornea"},{"key":"2749_CR9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00003226-200009000-00008","volume":"19","author":"MR Dana","year":"2000","unstructured":"Dana MR, Qian Y, Hamrah P (2000) Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection. Cornea 19:625\u2013643","journal-title":"Cornea"},{"key":"2749_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","volume":"1","author":"J Folkman","year":"1995","unstructured":"Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27\u201331","journal-title":"Nat Med"},{"key":"2749_CR11","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/blood-2010-02-267427","volume":"117","author":"S Nakao","year":"2011","unstructured":"Nakao S, Zandi S, Hata Y et al (2011) Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis. Blood 117:1081\u20131090. doi: 10.1182\/blood-2010-02-267427","journal-title":"Blood"},{"key":"2749_CR12","doi-asserted-by":"crossref","first-page":"11405","DOI":"10.1073\/pnas.0506112103","volume":"103","author":"C Cursiefen","year":"2006","unstructured":"Cursiefen C, Chen L, Saint-Geniez M et al (2006) Nonvascular VEGF receptor 3 expression by corneal epithelium maintains avascularity and vision. Proc Natl Acad Sci U S A 103:11405\u201311410. doi: 10.1073\/pnas.0506112103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2749_CR13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0002-9440(10)63630-9","volume":"163","author":"P Hamrah","year":"2003","unstructured":"Hamrah P, Chen L, Zhang Q, Dana MR (2003) Novel expression of vascular endothelial growth factor receptor (VEGFR)-3 and VEGF-C on corneal dendritic cells. Am J Pathol 163:57\u201368. doi: 10.1016\/S0002-9440(10)63630-9","journal-title":"Am J Pathol"},{"key":"2749_CR14","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.exer.2004.06.028","volume":"79","author":"P Hamrah","year":"2004","unstructured":"Hamrah P, Chen L, Cursiefen C et al (2004) Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) on monocytic bone marrow-derived cells in the conjunctiva. Exp Eye Res 79:553\u2013561. doi: 10.1016\/j.exer.2004.06.028","journal-title":"Exp Eye Res"},{"key":"2749_CR15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1167\/iovs.11-8668","volume":"53","author":"AR Hajrasouliha","year":"2012","unstructured":"Hajrasouliha AR, Funaki T, Sadrai Z et al (2012) Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis. Invest Ophthalmol Vis Sci 53:1244\u20131250. doi: 10.1167\/iovs.11-8668","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nm1078","volume":"10","author":"L Chen","year":"2004","unstructured":"Chen L, Hamrah P, Cursiefen C et al (2004) Vascular endothelial growth factor receptor-3 mediates induction of corneal alloimmunity. Nat Med 10:813\u2013815. doi: 10.1038\/nm1078","journal-title":"Nat Med"},{"key":"2749_CR17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-10-36","volume":"10","author":"H Yang","year":"2011","unstructured":"Yang H, Kim C, Kim M-J et al (2011) Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer. Mol Cancer 10:36. doi: 10.1186\/1476-4598-10-36","journal-title":"Mol Cancer"},{"key":"2749_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/84651","volume":"7","author":"T M\u00e4kinen","year":"2001","unstructured":"M\u00e4kinen T, Jussila L, Veikkola T et al (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7:199\u2013205. doi: 10.1038\/84651","journal-title":"Nat Med"},{"key":"2749_CR19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1189\/jlb.1011500","volume":"91","author":"T Hattori","year":"2012","unstructured":"Hattori T, Saban DR, Emami-Naeini P et al (2012) Donor-derived, tolerogenic dendritic cells suppress immune rejection in the indirect allosensitization-dominant setting of corneal transplantation. J Leukoc Biol 91:621\u2013627. doi: 10.1189\/jlb.1011500","journal-title":"J Leukoc Biol"},{"key":"2749_CR20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00007890-199210000-00026","volume":"54","author":"Y Sonoda","year":"1992","unstructured":"Sonoda Y, Streilein JW (1992) Orthotopic corneal transplantation in mice\u2013evidence that the immunogenetic rules of rejection do not apply. Transplantation 54:694\u2013704","journal-title":"Transplantation"},{"key":"2749_CR21","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2353\/ajpath.2009.080515","volume":"175","author":"E-S Chung","year":"2009","unstructured":"Chung E-S, Chauhan SK, Jin Y et al (2009) Contribution of macrophages to angiogenesis induced by vascular endothelial growth factor receptor-3-specific ligands. Am J Pathol 175:1984\u20131992. doi: 10.2353\/ajpath.2009.080515","journal-title":"Am J Pathol"},{"key":"2749_CR22","first-page":"413","volume":"37","author":"JW Streilein","year":"1996","unstructured":"Streilein JW, Bradley D, Sano Y, Sonoda Y (1996) Immunosuppressive properties of tissues obtained from eyes with experimentally manipulated corneas. Invest Ophthalmol Vis Sci 37:413\u2013424","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR23","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.1203469","volume":"192","author":"SK Chauhan","year":"2014","unstructured":"Chauhan SK, Saban DR, Dohlman TH, Dana R (2014) CCL-21 conditioned regulatory T cells induce allotolerance through enhanced homing to lymphoid tissue. J Immunol 192:817\u2013823. doi: 10.4049\/jimmunol.1203469","journal-title":"J Immunol"},{"key":"2749_CR24","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1167\/iovs.12-9609","volume":"53","author":"W Stevenson","year":"2012","unstructured":"Stevenson W, Cheng S-F, Emami-Naeini P et al (2012) Gamma-irradiation reduces the allogenicity of donor corneas. Invest Ophthalmol Vis Sci 53:7151\u20137158. doi: 10.1167\/iovs.12-9609","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR25","doi-asserted-by":"crossref","first-page":"6529","DOI":"10.1167\/iovs.11-7454","volume":"52","author":"H Zhang","year":"2011","unstructured":"Zhang H, Grimaldo S, Yuen D, Chen L (2011) Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival. Invest Ophthalmol Vis Sci 52:6529\u20136535. doi: 10.1167\/iovs.11-7454","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR26","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1002\/ijc.23439","volume":"122","author":"A Thelen","year":"2008","unstructured":"Thelen A, Scholz A, Benckert C et al (2008) VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma. Int J Cancer 122:2471\u20132481. doi: 10.1002\/ijc.23439","journal-title":"Int J Cancer"},{"key":"2749_CR27","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1016\/j.ajpath.2010.12.027","volume":"178","author":"Y Jin","year":"2011","unstructured":"Jin Y, Chauhan SK, El Annan J et al (2011) A novel function for programmed death ligand-1 regulation of angiogenesis. Am J Pathol 178:1922\u20131929. doi: 10.1016\/j.ajpath.2010.12.027","journal-title":"Am J Pathol"},{"key":"2749_CR28","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","volume":"172","author":"F Mor","year":"2004","unstructured":"Mor F, Quintana FJ, Cohen IR (2004) Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 172:4618\u20134623","journal-title":"J Immunol"},{"key":"2749_CR29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3109\/10428194.2012.726720","volume":"54","author":"IH Pedersen","year":"2013","unstructured":"Pedersen IH, Willerslev-Olsen A, Vetter-Kauczok C et al (2013) Vascular endothelial growth factor receptor-3 expression in mycosis fungoides. Leuk Lymphoma 54:819\u2013826. doi: 10.3109\/10428194.2012.726720","journal-title":"Leuk Lymphoma"},{"key":"2749_CR30","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1182\/blood-2012-08-453043","volume":"121","author":"N Singh","year":"2013","unstructured":"Singh N, Tiem M, Watkins R et al (2013) Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity. Blood 121:4242\u20134249. doi: 10.1182\/blood-2012-08-453043","journal-title":"Blood"},{"key":"2749_CR31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1167\/iovs.03-0803","volume":"45","author":"MR Dana","year":"2004","unstructured":"Dana MR (2004) Corneal antigen-presenting cells: diversity, plasticity, and disguise: the Cogan lecture. Invest Ophthalmol Vis Sci 45:722\u2013727, 721","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2749_CR32","first-page":"626","volume":"13","author":"Y Jin","year":"2007","unstructured":"Jin Y, Shen L, Chong E-M et al (2007) The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis 13:626\u2013634","journal-title":"Mol Vis"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2749-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-014-2749-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-014-2749-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:44Z","timestamp":1559058044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-014-2749-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["2749"],"URL":"https:\/\/doi.org\/10.1007\/s00417-014-2749-5","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}